We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 3,239 results
  1. False negative rate at 18F-FDG PET/CT in para-aortic lymphnode involvement in patients with locally advanced cervical cancer: impact of PET technology

    Background

    The identification of factors responsible for false negative (FN) rate at 18 F- Fluorodeoxyglucose (FDG) Positron Emission Tomography...

    Sebastien Gouy, Veronika Seebacher, ... Désirée Deandreis in BMC Cancer
    Article Open access 06 February 2021
  2. Correlation of [18F] FDG-PET/CT with dosimetry data: recurrence pattern after radiotherapy for head and neck carcinoma

    Objective

    To analyze the pattern of failure in relation to pre-treatment [ 18 F] FDG-PET/CT uptake in head and neck squamous cell carcinoma (HNSCC)...

    C. Pisani, L. Vigna, ... M. Krengli in Radiation Oncology
    Article Open access 21 March 2021
  3. Clinical utility of combined assessments of 4D volumetric perfusion CT, diffusion-weighted MRI and 18F-FDG PET-CT for the prediction of outcomes of head and neck squamous cell carcinoma treated with chemoradiotherapy

    Background

    Multiparametric imaging has been seen as a route to improved prediction of chemoradiotherapy treatment outcomes. Four-dimensional...

    Hirokazu Tsuchiya, Munetaka Matoba, ... Hiroyuki Tuji in Radiation Oncology
    Article Open access 06 February 2023
  4. Prognostic factors associated with 18FDG-PET/CT in esophageal squamous cell carcinoma after trimodality treatment

    Purpose

    This study aimed to determine the pathological complete response (pCR), overall survival (OS), and disease-free survival (DFS) in patients...

    Wei-Hsiang Feng, Ying-Yi Chen, ... Tsai-Wang Huang in BMC Cancer
    Article Open access 14 July 2022
  5. Prognostic value of 18F-FDG PET and PET/CT for assessment of treatment response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis

    Background

    We performed a systematic review and meta-analysis to evaluate the prognostic significance of 18 F-FDG PET and PET/CT for evaluation of...

    Sangwon Han, Joon Young Choi in Breast Cancer Research
    Article Open access 31 October 2020
  6. Evaluation of 18F-FDG PET/CT images acquired with a reduced scan time duration in lymphoma patients using the digital biograph vision

    Background

    The superior accuracy and sensitivity of 18 F-FDG-PET/CT in comparison to morphological imaging alone leads to an upstaging in up to 30% of...

    Manuel Weber, Walter Jentzen, ... David Kersting in BMC Cancer
    Article Open access 14 January 2021
  7. Prognostic value of metabolic tumor volume and total lesion glycolysis on preoperative 18F-FDG PET/CT in patients with localized primary gastrointestinal stromal tumors

    Background

    This study aimed to evaluate the prognostic value of pretreatment 18 F-fluorodeoxyglucose positron emission tomography/computed tomography (

    Sang Hyun Hwang, Minkyu Jung, ... Arthur Cho in Cancer & Metabolism
    Article Open access 28 January 2021
  8. Utility of 18F-FDG PET/CT for predicting pathologic complete response in hormone receptor-positive, HER2-negative breast cancer patients receiving neoadjuvant chemotherapy

    Background

    Pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC) is a predictor of improved outcomes in breast cancer. In patients...

    In Hee Lee, Soo Jung Lee, ... Yee Soo Chae in BMC Cancer
    Article Open access 16 November 2020
  9. Diagnostic accuracy and clinical value of [68Ga]Ga-FAPI-46 PET/CT for staging patients with ovarian cancer: study protocol for a prospective clinical trial

    Background

    [ 18 F]Fluorodeoxyglucose ([ 18 F]FDG) positron emission tomography (PET) is recommended during diagnostic work-up for ovarian cancer;...

    Morten Bentestuen, Morten Ladekarl, ... Helle D. Zacho in BMC Cancer
    Article Open access 07 June 2024
  10. Impact of FAPI-46/dual-tracer PET/CT imaging on radiotherapeutic management in esophageal cancer

    Background

    Fibroblast activation protein (FAP) is expressed in the tumor microenvironment (TME) of various cancers. In our analysis, we describe the...

    Simone Wegen, Karina Claus, ... Jasmin Josefine Weindler in Radiation Oncology
    Article Open access 04 April 2024
  11. Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [18F]FDG PET and CT perfusion: a prospective exploratory clinical study

    Background

    Stereotactic ablative radiation therapy (SABR) is effective in treating inoperable stage I non-small cell lung cancer (NSCLC), but imaging...

    Dae-Myoung Yang, David A. Palma, ... Ting-Yim Lee in Radiation Oncology
    Article Open access 13 January 2021
  12. Cancer Staging with 18F-FDG PET/CT in Hyperglycemic Patients

    In oncology positron emission tomography/computed tomography (PET/CT) is a standard imaging procedure for cancer staging, restaging, treatment...
    Monica Finessi, Virginia Liberini, Désirée Deandreis in Obesity and Diabetes
    Chapter 2020
  13. Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial)

    Efficacy of the human epidermal growth factor receptor (HER)2-targeting trastuzumab emtansine (T-DM1) in breast cancer (BC) relies on HER2 status...

    Magdalena Mileva, Elisabeth G. E. de Vries, ... Géraldine Gebhart in npj Breast Cancer
    Article Open access 06 January 2024
  14. Imaging features and prognostic value of 18F-FDG PET/CT detection of soft-tissue metastasis from lung cancer: a retrospective study

    Background

    Soft-tissue metastasis (STM) is a relatively rare, but not exceptional, manifestation of lung cancer. The purpose of this study was to...

    Tingting Xu, **nyi Zhang, ... Yue Chen in BMC Cancer
    Article Open access 26 June 2020
  15. Clinical application of real-time PET/CT guided targeted retroperitoneal masses biopsy in diagnosing malignant tumors

    Objective

    To explore the feasibility, safety, and clinical application value based on the fusion image of 18 F-FDG PET/CT, for guiding retroperitoneal...

    **aomin Li, Wanchun Zhang in BMC Cancer
    Article Open access 05 September 2023
  16. Prognostic value of metabolic activity of the psoas muscle evaluated by preoperative 18F-FDG PET-CT in breast cancer: a retrospective cross-sectional study

    Background

    This study aimed to evaluate the potential of metabolic activity of the psoas muscle measured by 18 F-fluorodeoxyglucose positron emission...

    Keunyoung Kim, In-Joo Kim, ... Hyojeong Kim in BMC Cancer
    Article Open access 27 October 2021
  17. A convolutional neural network-based system to classify patients using FDG PET/CT examinations

    Background

    As the number of PET/CT scanners increases and FDG PET/CT becomes a common imaging modality for oncology, the demands for automated...

    Keisuke Kawauchi, Sho Furuya, ... Tohru Shiga in BMC Cancer
    Article Open access 17 March 2020
  18. Differentiation of suprasellar meningiomas from non-functioning pituitary macroadenomas by 18F-FDG and 13N-Ammonia PET/CT

    Background

    Differentiation of suprasellar meningiomas (SSMs) from non-functioning pituitary macroadenomas (NFPMAs) is useful for clinical management....

    Lei Ding, Fangling Zhang, ... **angsong Zhang in BMC Cancer
    Article Open access 17 June 2020
Did you find what you were looking for? Share feedback.